This context matters because it suggests GLP-1 therapy may not be uniquely catabolic, but rather an efficient inducer of sustained energy deficit
TRESIBA is a man made insulin that is used to control high blood sugar in adults and children who are 1 year of age and older with diabetes mellitus
[ Links ] Sugiura T, Kobayashi Y, Oka S, et al (2002) Prostaglandins, Leukotrienes and Essential Fatty Acids 66: 173-192
While some brands remain stable at room temperature, storing it in the fridge can help extend its shelf life
Other GLP-1 receptor agonists include semaglutide (Wegovy for weight management, Ozempic for diabetes) and liraglutide (Saxenda for weight management, Victoza for diabetes), with semaglutide 2.4 mg demonstrating greater average weight loss than liraglutide 3.0 mg in clinical trials